Reply to Improda, N.; Ballarin, G. Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on "Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Children 2025, 12, 1427".
Saved in:
| Title: | Reply to Improda, N.; Ballarin, G. Body Composition in Paediatric GLP-1 Receptor Agonist Therapy. Comment on "Zaitoon et al. Beyond Weight Loss: Optimizing GLP-1 Receptor Agonist Use in Children. Children 2025, 12, 1427". |
|---|---|
| Authors: | Zaitoon H; Division of Pediatric Endocrinology and Diabetes, University of Texas Health Science Center, San Antonio, TX 78229, USA., Wauters AD; Division of Pediatric Endocrinology and Diabetes, University of Texas Health Science Center, San Antonio, TX 78229, USA., Rodriguez LM; Division of Pediatric Endocrinology and Diabetes, University of Texas Health Science Center, San Antonio, TX 78229, USA., Lynch JL; Division of Pediatric Endocrinology and Diabetes, University of Texas Health Science Center, San Antonio, TX 78229, USA. |
| Source: | Children (Basel, Switzerland) [Children (Basel)] 2026 Apr 28; Vol. 13 (5). Date of Electronic Publication: 2026 Apr 28. |
| Publication Type: | Comment; Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101648936 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9067 (Print) Linking ISSN: 22279067 NLM ISO Abbreviation: Children (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2227-9067 |
|---|---|
| DOI: | 10.3390/children13050608 |
